Search details
1.
Treatment of residual disease following neoadjuvant therapy in breast cancer.
J Surg Oncol
; 129(1): 18-25, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37990834
2.
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Breast Cancer Res
; 25(1): 112, 2023 10 02.
Article
in English
| MEDLINE | ID: mdl-37784176
3.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37589839
4.
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
J Natl Compr Canc Netw
; 21(6): 594-608, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37308117
5.
Margetuximab in HER2-positive metastatic breast cancer.
Future Oncol
; 19(16): 1099-1112, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37170847
6.
Coping strategies and psychosocial resources among women living with metastatic breast cancer: A qualitative study.
J Psychosoc Oncol
; : 1-17, 2023 Sep 12.
Article
in English
| MEDLINE | ID: mdl-37698184
7.
Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.
Cancer
; 128(9): 1738-1747, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35137951
8.
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(6): 691-722, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35714673
9.
Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination.
Psychooncology
; 31(3): 425-435, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34546611
10.
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy.
Support Care Cancer
; 30(8): 6613-6622, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35488902
11.
A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention.
J Behav Med
; 45(5): 771-781, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35930212
12.
De-escalation of Endocrine Therapy in Early Hormone Receptor-positive Breast Cancer: When Is Local Treatment Enough?
Ann Surg
; 274(4): 654-663, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34506321
13.
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Oncologist
; 26(8): e1327-e1338, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34028126
14.
The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis.
Breast Cancer Res Treat
; 185(3): 667-676, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33070279
15.
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
Breast Cancer Res Treat
; 186(2): 429-437, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33392838
16.
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.
Breast Cancer Res Treat
; 187(2): 397-405, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34076801
17.
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Breast Cancer Res Treat
; 188(2): 449-458, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33909203
18.
Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.
Ann Surg Oncol
; 28(13): 8717-8727, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34250555
19.
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
J Natl Compr Canc Netw
; 19(5): 484-493, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-34794122
20.
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
Breast Cancer Res Treat
; 181(3): 487-497, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32333293